Nipro
Company Snapshot
Founded: 1947
Entity Type: Public
Employees: 39,168
Region: Japan
Revenue: $4,234.9 Millions
Revenue Year: 2024
Headquarter: Osaka, Japan
Key Geographics: Japan, Americas, Europe, Chin, Other Asia
Corporate Address: 3-26, Senriokashinmachi, Settsu, Osaka, 566-8510 Japan www.nipro.co.jp
Company Overview
Nipro is a medical technology company with a strong presence across Asia, Europe, and the Americas. The company operates through three primary segments: medical devices, pharmaceutical packaging, and pharmaceuticals. Its medical device portfolio includes dialysis systems, vascular access devices, injection systems, diagnostic tools, and diabetes care products. Its manufacturing infrastructure supports its global supply, with ISO-certified facilities across Japan (Tatebayashi, Odate, Biwa), India, China, Thailand, and Brazil.
Financial Highlights (FY 2024)
Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
Operating Income: ***
This information is available for BCC Research members only.
Nipro In News
Company's Business Segments
- Medical-Related : Medical-Related segment include Medical Devices, Pharmaceuticals, Domestic Business. Like Dialysis Equipment, Infusion-Related Products, Testing Products , Sd-Related Products, Vascular-Related Products,Oral Drugs, Nexium Ag, In-Vitro Diagnostics, many others.
- Pharmaceutical-Related : Pharmaceutical-Related segment includes Generic Drugs, Brand-Name Drugs, Long-Listed Drugs, OTC Drugs, Active Ingredients, Jmi Pharma, many others.
- Pharma Packaging Business : Pharma Packaging Business segment includes Infusion-Related Products, Needles Sales Of Products For Other Companies.
- Other : Other segment includes Sales of Production Machinery and Real Estate Leasing.
Applications/End User Industries
- Medical Devices
- Pharmaceuticals
- Pharmacies
- Hospitals
- Clinics
- Healthcare
- Dialysis
- Vascular Products
- Oral Drugs
- In-Vitro Diagnostics
- Pharma Packing
- Needles Manufacturing
- OTC Retailers
- Glass Tubes
- Injections
BCC Research Beacon 